Figure 3 — Therapeutic strategies and predictive models for Xp11.2 translocation/TFE3 gene fusion renal cell carcinoma in adults based on data of two Chinese medical centers

Research Paper|Volume 16, Issue 2|pp. 1696–1711

Therapeutic strategies and predictive models for Xp11.2 translocation/TFE3 gene fusion renal cell carcinoma in adults based on data of two Chinese medical centers

Back to articleFigure 3(3 of 7)

100%

Figure 3.Calibration curve and ROC curve. Discrimination of the nomogram was evaluated by the ROC curve, AUC = 0.796 in the Ra cohort (A), AUC = 0.806 in the Ha cohort (B); calibration curves illuminate the agreement between the predicted risks of TFE3-RCC (C) and the observed incidence of TFE3-RCC (D). The dotted line represents the ideal flawless model.